ketamine has been researched along with Uterine Neoplasms in 1 studies
Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
Uterine Neoplasms: Tumors or cancer of the UTERUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fifty-six patients undergoing UAE embolization for treatment of symptomatic uterine leiomyomata were randomized to receive either 2 mg/ml of morphine (Control group, n=30) or 2 mg/ml of both morphine and ketamine (Ketamine group, n=26) by i." | 5.13 | No morphine sparing effect of ketamine added to morphine for patient-controlled intravenous analgesia after uterine artery embolization. ( Handberg, G; Helbo-Hansen, HS; Jensen, LL; Lohse, T; Lund, N; Munk, T; Skaarup, I, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jensen, LL | 1 |
| Handberg, G | 1 |
| Helbo-Hansen, HS | 1 |
| Skaarup, I | 1 |
| Lohse, T | 1 |
| Munk, T | 1 |
| Lund, N | 1 |
1 trial available for ketamine and Uterine Neoplasms
| Article | Year |
|---|---|
No morphine sparing effect of ketamine added to morphine for patient-controlled intravenous analgesia after uterine artery embolization.
Topics: Adult; Analgesia; Analgesia, Patient-Controlled; Analgesics; Analgesics, Opioid; Drug Therapy, Combi | 2008 |